Profile of Sofosbuvir and Velpatasvir Combination in the Treatment of Chronic Hepatitis C in Children and Adolescents: Current Evidence
Dania Brigham, Michael R Narkewicz Digestive Health Institute, Pediatric Liver Center, Children's Hospital Colorado and University of Colorado School of Medicine, Section of Pediatric Gastroenterology, Hepatology and Nutrition, Aurora, CO, USACorrespondence: Michael R Narkewicz, Email michael.n...
Saved in:
Main Authors: | Brigham D (Author), Narkewicz MR (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics of Sofosbuvir/Velpatasvir and efficacy of an alternate‐day treatment in hemodialysis patients with chronic hepatitis C infection
by: Pajaree Chariyavilaskul, et al.
Published: (2024) -
Eight-week treatment with sofosbuvir/velpatasvir may be effective in curing hepatitis C in children
by: Maria Pokorska-Śpiewak, et al.
Published: (2024) -
Sofosbuvir/velpatasvir regimen promises an effective pan-genotypic hepatitis C virus cure
by: Mir F, et al.
Published: (2017) -
Experience with Sofosbuvir/Velpatasvir for the treatment of chronic hepatitis C in children with transfusion-dependent thalassemia: A single centre study
by: Nidhi Kumari, et al.
Published: (2022) -
A comparison of sofosbuvir/velpatasvir and glecaprevir/pibrentasvir for the treatment of hepatitis C infection among people who inject drugs
by: Shana Yi, et al.
Published: (2024)